# Aozida

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aozida

- Industry: Health & Biotech
- Headquarters: Guangzhou, China
- Total disclosed funding: $15M
- Latest round: Series D (Nov 13, 2026)
- Investors on record: 0

## About

Guangzhou-based Aozida (Osmunda) raised a 100 million CNY Series D round led exclusively by the Lishui Lvgu Talent Osmunda New Fund. The medical device CRDMO platform will use the money to build an MAH mass-production plant, a provincial proof-of-concept and pilot facility, and to develop its medical device vertical AI model and agents.

## Funding rounds

- Series D, Nov 13, 2026, $15M